Skip to main content

Animations

MJFF Publications

6301 - 6325 of 9038 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2018
  • 2018
  • 2018
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Evaluation of ATN PD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000208033
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Nova-ST: Nano-patterned ultra-dense platform for spatial transcriptomics
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100831
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2024.101669
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Contrastive machine learning reveals Parkinson’s disease specific features associated with disease severity and progression
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s42003-024-06648-x
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The digital signature of emergent tremor in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00754-7
    Citation Count: 6
  • Summary Details
    OPEN
    Title: LRRK2 kinase activity is necessary for development and regeneration in Nematostella vectensis
    Journal Name: Neural Development
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s13064-024-00193-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: A worldwide study of white matter microstructural alterations in people living with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00758-3
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2402206121
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Long-Term Dementia Risk in Parkinson Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000209699
    Citation Count: 73
  • Summary Details
    OPEN
    Title: Visualizing chaperone-mediated multistep assembly of the human 20S proteasome
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41594-024-01268-9
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Loss-of-function variants in ITSN1 confer high risk of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00752-9
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders
    Journal Name: GeroScience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11357-024-01120-4
    Citation Count: 10
  • Summary Details
    OPEN
    Title: DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease
    Journal Name: GeroScience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11357-024-01116-0
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Structural parameters are superior to eigenvector centrality in detecting progressive supranuclear palsy with machine learning & multimodal MRI
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2024.e34910
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0282-4
    Citation Count: 263
  • Summary Details
    OPEN
    Title: Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins
    Journal Name: The EMBO Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embr.201745680
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-31988-0
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-023-01433-w
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-023-01440-x
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1280218
    Citation Count: 9
  • Summary Details
    OPEN
    Title: PTPA variants and the risk for Parkinson’s disease in diverse ancestry populations
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awad247
    Citation Count: 6
  • Summary Details
    OPEN
    Title: In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-023-02080-x
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00604-y
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Development and Pilot Testing of the Tremor Retrainer Smartphone Application for the Treatment of Functional Tremor
    Journal Name: Tremor and Other Hyperkinetic Movements
    Publisher: Ubiquity Press, Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.5334/tohm.823
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.91645
    Citation Count: 63
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.